Detection of hepatitis C core antigen in the antibody negative 'window' phase of hepatitis C infection.
about
Hepatitis C-Z: recent advancesUsefulness of the Hepatitis C Virus Core Antigen Assay for Screening of a Population Undergoing Routine Medical CheckupNonenveloped Nucleocapsids of Hepatitis C Virus in the Serum of Infected PatientsSimultaneous Detection of Hepatitis C Virus (HCV) Core Antigen and Anti-HCV Antibodies Improves the Early Detection of HCV InfectionFrequency of gC1qR+CD4+ T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection.Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening.Feasibility and cost-benefit of implementing pooled screening for HCVAg in small blood bank settings.Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patientsIncidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohortViral safety of haemophilia treatment products.Detection of hepatitis C virus core antigen for early diagnosis of hepatitis C virus infection in plasma donor in China.Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming anti-HCV resultsHost and viral factors in the immunopathogenesis of primary hepatitis C virus infection.Hepatitis C core Ag and its clinical applicability: potential advantages and disadvantages for diagnosis and follow-up?Current testing strategies for hepatitis C virus infection in blood donors and the way forwardEfficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of 'window-phase' blood donations.A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection.Electrochemical Biosensors - Sensor Principles and Architectures.HCV Ag quantification as a one-step procedure in diagnosing chronic hepatitis C infection in Cameroon: the ANRS 12336 study.Can Hepatitis C Virus Antigen Testing Replace Ribonucleic Acid Polymearse Chain Reaction Analysis for Detecting Hepatitis C Virus? A Systematic Review.Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen.Introduction of an automated system for the diagnosis and quantification of hepatitis B and hepatitis C viruses.Detection of free hepatitis C virus core antigen by enzyme-linked immunosorbent assay is not suitable for screening of granulocyte colony-stimulating factor-mobilized hematopoietic progenitor donors.Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors.Long-term evolution of serum and liver viral markers in patients treated for chronic hepatitis C and sustained response.Efficacy of HCV core antigen detection during the preseroconversion period.Accuracy of hepatitis C virus core antigen testing in pools among seroconverters.HCV core antigen assay.Detection of HCV core antigen in human serum and plasma with an automated chemiluminescent immunoassay.Quantification of HCV RNA levels and detection of core antigen in donations before seroconversion.Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase.A new HCV core antigen assay based on disassociation of immune complexes: an alternative to molecular biology in the diagnosis of early HCV infection.Detection of a healthy carrier of HCV with no evidence of antibodies for over four years.Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy.Application of a new enzyme-linked immunosorbent assay for detection of total hepatitis C virus core antigen in blood donors.Optimising diagnosis of viraemic hepatitis C infection: the development of a target product profile.De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.Hepatitis C core antigen in Polish blood donors.Performance of ORTHO HCV core antigen and trak-C assays for detection of viraemia in pre-seroconversion plasma and whole blood donors.Residual risk of transfusion-transmitted HCV and HIV infections by antibody-screened blood in Italy.
P2860
Q24676346-F2429E65-2B10-4C81-AA53-64AE04624576Q27469465-10CF7FB6-AFB4-4B05-855B-71DF21F6FFE0Q27469952-6608E9B3-0AF3-4DF6-8D40-683010641153Q27471998-486CCF08-EB6D-4B3E-9DDB-F70F382AD812Q30434900-E821302F-910E-4D70-9594-7BADA3FDE37EQ31050666-1C6D5287-82CC-4719-A263-DFAA1DCCAC7EQ33450364-81092888-BD73-4665-BEF9-E88419D8D5FAQ33592762-084092A7-0BE8-49FA-842E-D22796C3CCEEQ33724826-DDCE9FC5-C18F-47AC-91CB-882C16B35723Q34087439-47233259-3117-4E54-9F6F-FEA42603157CQ34100073-C6B38D9B-EA44-4E42-B8A4-B0303D92D659Q35599069-D5A011B2-9E9C-4011-B8C8-317F7CA4D77EQ36666331-30E7F41D-7DF8-4500-9123-C62BD57B67EFQ37961619-1405E0C4-973C-4886-84CF-348A2F0A3ECBQ38198619-FC2866E3-A80A-4DFF-A8B8-487F10374467Q38461450-891B9733-B1A6-4027-B156-C00F4FFE906AQ38883263-A81A52E2-70BF-4DDB-A027-137E0B501099Q39018116-119C5E64-3431-4B87-9890-D9F9ADC9EFE1Q39321794-1DEC1AFE-4B32-4C43-A3E8-C8E1835A5CC1Q39342907-0A52DC08-63D2-41B9-8001-19720302F033Q39466003-59E6A6B2-AE8C-4778-B90E-7D9238E7FE02Q41809253-656290D5-59CE-4E32-8223-AF7AD8CF512CQ42989343-124FBE71-1CB0-4C9B-8748-9D95DBAF896BQ42996328-050D44F5-3524-4418-AE70-92343BA868EBQ42997222-5BE0A1C0-2071-4C16-ACD6-C4C8CC9783F8Q43000848-89DCFCC8-74C2-437E-A748-61DEFF265AA3Q43031733-99BDB600-8834-4248-8CB9-F1099B484634Q43034238-314B2D0E-AF45-40DF-8FB3-C03D3567A30DQ43037481-7FF99668-4BCA-43F7-AC24-15E0AF242567Q43040539-1B5AFEF1-FE32-4747-99B6-6048B8EFCEA6Q43040540-4CEA5DD2-A097-473D-B929-C9C1C74532E9Q43047991-A8A6C9BF-7E9D-4D62-92A1-A8546077B646Q43047994-E34A35E8-4F35-4086-87F0-451EF0F714CCQ43049351-488C145A-6633-46EE-A333-A13CC1422204Q45709781-235BB0C8-E500-4898-BC29-1FC00B64ADCBQ46388033-FB087BBC-964D-4EF8-ACB4-9ED1AD6FA12FQ46414212-56596D39-7333-43CD-A187-B71B1854E7E8Q47269593-508500CB-6CF9-46FA-BDCB-37D13DB371C9Q50750366-887833D0-5FE8-4603-9E28-621FB54B0BB4Q52030298-CFBAD290-A8E9-490D-B3B6-CDAB87235425
P2860
Detection of hepatitis C core antigen in the antibody negative 'window' phase of hepatitis C infection.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Detection of hepatitis C core ...... hase of hepatitis C infection.
@en
Detection of hepatitis C core ...... hase of hepatitis C infection.
@nl
type
label
Detection of hepatitis C core ...... hase of hepatitis C infection.
@en
Detection of hepatitis C core ...... hase of hepatitis C infection.
@nl
prefLabel
Detection of hepatitis C core ...... hase of hepatitis C infection.
@en
Detection of hepatitis C core ...... hase of hepatitis C infection.
@nl
P2093
P2860
P1433
P1476
Detection of hepatitis C core ...... hase of hepatitis C infection.
@en
P2093
Caldwell B
Kerrison P
Peterson J
P2860
P356
10.1046/J.1423-0410.2000.7820080.X
P577
2000-01-01T00:00:00Z